The import of blood, antisera, vaccines, toxins, and cultures to Malaysia has experienced fluctuations over the past decade, with significant growth in some years followed by periods of minor decline or stabilization. In 2023, the import value stood at 178.92 million USD, representing a slight increase of 3.67% from the previous year. The compound annual growth rate (CAGR) over the last five years (2018-2023) was 2.98%, indicating moderate growth. The forecast for 2024 shows continued optimism with an import value of 186.41 million USD.
Future trends to watch for:
- Efforts to improve healthcare infrastructure and increase vaccination rates may drive up demand.
- Global health initiatives and pandemic response efforts may impact import volumes.
- Market shifts toward new health technologies and treatments can influence import dynamics.
